Trials / Completed
CompletedNCT04408014
Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo
Seroepidemiological Study of SARS-CoV-2 Infection in Population Subgroups in the State of São Paulo
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 18,901 (actual)
- Sponsor
- Butantan Institute · Other Government
- Sex
- All
- Age
- 6 Months – 100 Years
- Healthy volunteers
- Accepted
Summary
Seroepidemiological Study of SARS-CoV-2 Infection in Population Subgroups in the State of São Paulo
Detailed description
This is a cross-sectional study to estimate the prevalence of antibodies against SARS-CoV-2 is different population subgroups in the State of São Paulo
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Serological test | IgM and IgG for SARS-CoV-2 |
| DIAGNOSTIC_TEST | Nasopharyngeal Swab | PCR for SARS-CoV-2 |
| DIAGNOSTIC_TEST | Oropharyngeal Swab | PCR for SARS-CoV-2 |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2020-07-15
- Completion
- 2020-07-30
- First posted
- 2020-05-29
- Last updated
- 2024-02-15
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT04408014. Inclusion in this directory is not an endorsement.